Stericycle (NASDAQ:SRCL) had its price objective reduced by equities research analysts at BMO Capital Markets from $72.00 to $64.00 in a note issued to investors on Friday. The firm presently has a “market perform” rating on the business services provider’s stock. BMO Capital Markets’ price objective indicates a potential upside of 5.56% from the stock’s current price.
Several other equities analysts have also issued reports on the stock. Royal Bank of Canada cut their price objective on shares of Stericycle from $75.00 to $61.00 and set an “underperform” rating on the stock in a report on Thursday. Robert W. Baird raised shares of Stericycle from an “underperform” rating to a “neutral” rating and set a $73.00 price target on the stock in a report on Tuesday, February 13th. BidaskClub raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 31st. Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 10th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $85.00 price target on shares of Stericycle in a report on Thursday, December 28th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $71.50.
Shares of Stericycle (NASDAQ SRCL) traded down $14.28 during mid-day trading on Friday, reaching $60.63. 7,423,200 shares of the company traded hands, compared to its average volume of 978,308. The stock has a market capitalization of $6,395.28, a price-to-earnings ratio of 233.20, a price-to-earnings-growth ratio of 1.76 and a beta of 0.26. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.93. Stericycle has a 12 month low of $58.53 and a 12 month high of $88.00.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Wednesday, February 21st. The business services provider reported $1.00 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.14 by ($0.14). The business had revenue of $887.80 million for the quarter, compared to analysts’ expectations of $882.62 million. Stericycle had a net margin of 1.18% and a return on equity of 13.94%. The business’s quarterly revenue was down 2.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.00 earnings per share. analysts anticipate that Stericycle will post 4.67 EPS for the current fiscal year.
In other Stericycle news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction on Monday, December 4th. The shares were sold at an average price of $67.43, for a total value of $1,331,944.79. The transaction was disclosed in a document filed with the SEC, which is available through this link. 3.50% of the stock is currently owned by insiders.
Several institutional investors and hedge funds have recently made changes to their positions in SRCL. NEXT Financial Group Inc grew its holdings in shares of Stericycle by 77.9% during the third quarter. NEXT Financial Group Inc now owns 2,322 shares of the business services provider’s stock valued at $164,000 after buying an additional 1,017 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its holdings in shares of Stericycle by 500.0% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 3,000 shares of the business services provider’s stock valued at $204,000 after buying an additional 2,500 shares during the last quarter. Balter Liquid Alternatives LLC purchased a new stake in shares of Stericycle during the fourth quarter valued at $206,000. Roberts Glore & Co. Inc. IL purchased a new stake in shares of Stericycle during the fourth quarter valued at $210,000. Finally, Investors Research Corp purchased a new stake in shares of Stericycle during the fourth quarter valued at $212,000. 92.57% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “BMO Capital Markets Trims Stericycle (SRCL) Target Price to $64.00” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/02/23/bmo-capital-markets-trims-stericycle-srcl-target-price-to-64-00.html.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.